Loading data for DERM — first visit, this takes a few seconds.
Journey Medical Corporation (DERM)
NasdaqCM: DERM
· 即時價格 · USD
7.09
-0.36 (-4.83%)
收盤價： Sep 11, 2026, 3:59 PM
7.23
+0.00%
盤後: 4:10 PM
股價、關鍵數字和最新消息，都在這一頁。
Journey Medical Corporation（DERM）股價、分析與資料
-4.83% (1D)
| 買價 | 5.33 |
| 市值 | 204M |
| 營收 (ttm) | 68.2M |
| 淨利（ttm） | -6.1M |
| 1.10 | |
| -0.22 | |
| n/a | |
| -120.5 | |
| P/B (ttm) | 6.23 |
| P/S (ttm) | 2.99 |
| 財報日期 | Nov 11, 2026 |
| 賣價 | 9.6 |
| 成交量 | 265,168 |
| 20 日平均成交量 | 242,047 |
| 開盤價 | 7.38 |
| 前收盤價 | 7.45 |
| 當日區間 | 7.05 - 7.70 |
| 52 週範圍 | 4.31 - 9.55 |
| 分析師 | n/a |
| 目標價 | n/a |
| 股利 | n/a |
| 除息日 | n/a |
關於 DERM
Journey Medical Corporation, a commercial-stage pharmaceutical company that focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant nodular acne; and Amzeeq, a topica...
完整的公司簡介財報驚奇
Journey Medical 已於 Aug 12, 2026 公布季度財報：
- 營收為 $15.96M 低於預期 $0, 年增 21.48% 成長.
- 每股盈餘為 -0.01 超出預期 0.01, 年增 93.75% 成長.
第 1 頁，共 2 頁